Excellis is an early-stage deep tech venture capital firm based in Turin, Italy, backing Italian researcher-founders building frontier technologies at the world's top institutions. The firm invests in seed and Series A rounds across robotics, new energy, healthcare innovation, and enabling technologies.
Portfolio
9
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
AE
Alberto Emprin
Managing Partner
LL
Loris Lanzellotti
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 MintNeuro | Unknown | — | Nov 2024 |
 Fluorok | Unknown | $7.7M | Jan 2024 |
 Zaphiro | Series A | — | Jan 2019 |
 Nagi Bioscience | Series A | — | — |
 Hylomorph | Series B | $5.2M | — |
 Hylomorph | Unknown | — | — |
 Nagi Bioscience | Unknown | — | — |
| HHylomorph AG | Series B | — | — |
| HHylomorph AG | Series A | — | — |
 Hylomorph | Unknown | — | — |
Top Co-Investors
Zürcher Kantonalbank6 shared
Verve Ventures6 shared
Club degli Investitori5 shared
imec.xpand2 shared
Volta Energy Technologies1 shared
BGF1 shared
Oxford Science Enterprises1 shared
Green Generation Fund1 shared
ABB Ventures1 shared
Fund+1 shared
CDP Venture Capital SGR S.p.A.1 shared
Plug and Play Tech Center1 shared
Parkwalk Advisors1 shared
Empirical Ventures1 shared
Swisscanto Private Equity1 shared
Last updated: 8 September 2026